Medication info
Telitoplus Tablet 40/12.5mg

Telitoplus Tablet 40/12.5mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Boryung Biopharma Co., Ltd.
Appearance
White or almost white, biconvex round tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201905397 · Approved 2019.07.30 · Insurance code 670501820

Summary

Main use
Treatment of essential hypertension inadequately controlled with telmisartan monotherapy
Who takes it
Adults · Children
Adult dose
Take orally once daily with a beverage, with or without food, in patients whose blood pressure is not adequately controlled with telmisartan alone. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the doses of each component be adjusted individually for the patient. When clinically appropriate, a direct switch from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg administered concomitantly as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dosage adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment Administer this medicine with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine once daily. Do not administer this medicine to patients with severe hepatic impairment (see Precautions for Use, 2.). Thiazide diuretics should be administered with caution to patients with impaired liver function. Older adults No dosage adjustment is necessary.
Child dose
The safety and efficacy of this medicine have not been established in children under 18 years of age.

Ingredients

Manufacturer
Boryung Biopharma Co., Ltd.

Efficacy & effects

Treatment of essential hypertension inadequately controlled with telmisartan monotherapy

  • Essential hypertension
View approved original text

This medication is primarily used to treat essential hypertension. It is especially used as an add-on for patients who have inadequate blood pressure control with telmisartan monotherapy, effectively lowering blood pressure. This helps in maintaining stable blood pressure and reducing the risk of complications from hypertension. Therefore, this medication plays a significant role in hypertension treatment and is utilized to improve the health of patients.

How to take

Adult dose

Take orally once daily with a beverage, with or without food, in patients whose blood pressure is not adequately controlled with telmisartan alone. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the doses of each component be adjusted individually for the patient. When clinically appropriate, a direct switch from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg administered concomitantly as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dosage adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment Administer this medicine with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine once daily. Do not administer this medicine to patients with severe hepatic impairment (see Precautions for Use, 2.). Thiazide diuretics should be administered with caution to patients with impaired liver function. Older adults No dosage adjustment is necessary.

Child dose

The safety and efficacy of this medicine have not been established in children under 18 years of age.

Precautions

This medication can cause serious risks to the fetus during pregnancy, particularly in the second and third trimesters, so it must be discontinued immediately if pregnancy is confirmed. This medication should not be used in patients with allergies to the active ingredients or excipients, or in those with certain liver or kidney diseases. Elderly patients or those with high potassium levels, liver impairment, or heart disease should use this medication with caution, and there may be an increased risk of skin cancer. Various adverse reactions such as dizziness, hypotension, and electrolyte imbalances may occur while taking this medication, so severe symptoms should be discussed with a healthcare professional. Particularly, this medication affects blood pressure control, so it should only be taken with other antihypertensives, diuretics, or lithium after consulting a doctor due to the risk of interactions and side effects. Pregnant or breastfeeding women should not take this medication, and those planning to conceive or who are pregnant should switch to a safer alternative. In case of overdose, symptoms such as hypotension, electrolyte abnormalities, or dehydration may appear; immediate medical attention is required. This medication is not recommended for children under 18 years of age as safety and effectiveness have not been established. Drowsiness and dizziness may occur while taking this medication, so caution is advised when driving or operating machinery. When storing, keep it out of reach of children and do not transfer to another container to ensure safety.

Side effects

  • Hypotension
  • neonatal craniosynostosis
  • anuria
  • renal failure
  • oligohydramnios
  • fetal limb contractions
  • craniofacial anomalies
  • pulmonary hypoplasia
  • prematurity
  • intrauterine growth restriction
Show 127 more
  • patent ductus arteriosus
  • bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorders
  • dizziness
  • syncope
  • paresthesia
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory distress
  • pulmonary inflammation
  • pulmonary edema
  • diarrhea
  • dry mouth
  • abdominal distension
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • gastritis
  • liver dysfunction
  • hepatic impairment
  • vascular edema
  • erythema
  • pruritus
  • rash
  • sweating
  • urticaria
  • back pain
  • muscle spasm
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased blood uric acid
  • increased blood creatinine
  • increased serum creatine phosphokinase
  • elevated liver enzymes
  • upper respiratory tract infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hypersensitivity
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • cough
  • dry mouth
  • abdominal discomfort
  • taste dysfunction
  • eczema
  • drug rash
  • toxic epidermal necrolysis
  • bone pain
  • renal dysfunction
  • asthenia
  • decreased hemoglobin
  • sialadenitis
  • non-melanoma skin cancer
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • aplastic anemia
  • photosensitivity reaction
  • hyponatremia
  • decreased appetite
  • hypomagnesemia
  • hyperglycemia
  • hypercalcemia
  • hypochloremic metabolic alkalosis
  • necrotizing vasculitis
  • acute respiratory distress syndrome
  • pancreatitis
  • jaundice
  • cholestasis
  • toxic epidermal necrolysis
  • erythema multiforme
  • systemic lupus erythematosus
  • acute renal failure
  • diabetes
  • asthenia
  • fever
  • nausea
  • gastrointestinal bleeding
  • esophagitis
  • headache
  • tremors
  • facial flushing
  • malaise
  • fatigue
  • weight loss
  • increased creatine phosphokinase
  • proteinuria
  • itching
  • myalgia
  • floating sensation
  • tremors of the lips and hands
  • hypersensitivity
  • periodontal disease
  • lip dryness
  • vision impairment
  • hypoglycemia
  • intestinal vascular edema
  • nausea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or humidity, so it should be stored in a tightly sealed container. Additionally, to maintain the drug's efficacy, it is best to store it at room temperature, between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White or almost white, biconvex round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.